Modulates the glutamate-activated nitric oxide synthase (NOS) pathway. Prepn: R. A. Stokbroekx, G. A. J. Grauwels, EP 501552; US 5434168 (1992, 1995 both to Janssen). Mechanism of action study: M. De Ryck et al., J. Pharmacol. Exp. Ther. 279, 748 (1996); A. S. Lesage et al., ibid. 759. Clinical pharmacokinetics: J. De Keyser et al., Clin. Ther. 19, 1340 (1997). Clinical trial in acute ischemic stroke: J. Grotta et al., Stroke 28, 2338 (1997).
Neuroprotective.
Neuroprotective